StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Here's a fun one:)

<< Previous

Bullboard Posts

Next >>

Post by Jonnyboy85on Apr 01, 2021 9:06pm

270 Views

Post# 32925866

Here's a fun one:)

"Consolidated revenue for the year ended December 31, 2020 was approximately $4,736,546XX reflecting the sales of tests. The revenue for the same period in 2019 was $139,000 while the revenue for the same period in 2018 was $186,000."

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing